Signal active
Investment Firm
Overview
Yield10 Bioscience is a biotechnology company that specializes in developing innovative crop yield improvement solutions using advanced genetic engineering and synthetic biology techniques. The company focuses on creating proprietary traits and technologies that can enhance the productivity and nutritional profile of various crops, with an emphasis on oilseed crops and other specialty crops. Yield10 Bioscience employs cutting-edge biotechnological tools to develop and test their plant traits and technologies. This includes utilizing techniques like gene editing, genome engineering, and metabolic engineering to introduce specific genetic modifications into plants that can lead to desired traits.
Highlights
1992
Biotechnology
11-50
1
1
1
Early Stage Venture
N/A
Location
United States, North America
Contact Information
Social
Profile Resume
Yield10 Bioscience, established in 1992 and headquartered in United States, North America., specializes in Early Stage Venture investments across Biotechnology, Health Care, Medical Device. The organization boasts a portfolio of 1 investments, with an average round size of $4.4M and 1 successful exits. Their recent investments include Tepha. The highest investment round they participated in was $53.0M. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Investment portfolio
1
0
1
1
Investments
1
Annouced Date | Organization Name | Industry | Money Raised |
---|---|---|---|
Mar 11, 2003 | Tepha | Biotechnology | 4.4M |
Exits
1
Funding Timeline
1
5
0
Funding Rounds
1
Yield10 Bioscience has raised 1 rounds. Their latest funding was raised on Mar 11, 2003 from a Series A - Tepha round.
Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
---|---|---|---|---|
Mar 11, 2003 | Series A - Tepha | - | 4.4M | - |
Investors
9
Yield10 Bioscience is funded by 9 investor(s). Jack W. Schuler Living Trust and Oracle Investment Management Inc. Kantor are the most recent investors.
Investor Name | Lead Investor | Funding Round | Money Raised |
---|---|---|---|
- | No | Post-IPO Equity - Yield10 Bioscience | 11.5M |
- | No | Post-IPO Equity - Yield10 Bioscience | 4.0M |
Jack W. Schuler Living Trust | Yes | Post-IPO Equity - Yield10 Bioscience | 12.7M |
- | No | Post-IPO Equity - Yield10 Bioscience | 3.7M |
Fund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
Annouced Date | Fund Name | Money Raised |
---|---|---|
May 10, 2013 | OTPPLESS | 1.0M |
May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
Recent Activity
There is no recent news or activity for this profile.